Diabetes drugs tied to lower prostate cancer risk
NEW YORK (Reuters Health) - Drugs used to control diabetes may lower the risk of prostate cancer, investigators at the University of Tampere in Finland report.
“Recent studies have reported a decreased prostate cancer risk for diabetic men, although the evidence is controversial,” Dr. Teemu J. Murtola and colleagues note in the American Journal of Epidemiology. “It is currently unclear whether use of antidiabetic medication affects the association between diabetes and prostate cancer.”